Skip to main content

Table 5 Biometric, lipoprotein profile distributions, assessment-insulin resistance and blood glucose distributions in relation to the PPARγ C161→T genotypes in T2DM patients

From: PPARγ gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus

  PARγ genotypes
  CC(n = 55) CT(n = 27) TT(n = 4) CT+TT(n = 31)
Age 58.13 ± 10.68 54.80 ± 11.05 56.50 ± 13.40 55.26 ± 12.21
Weight (kg) 66.10 ± 12.15 62.30 ± 9.06 69.38 ± 12.93 63.79 ± 10.02
Height (m) 1.65 ± 0.09 1.63 ± 0.07 1.66 ± 0.09 1.64 ± 0.07
BMI (kg/m2) 24.69 ± 4.65 23.04 ± 3.36 25.08 ± 4.67 23.62 ± 3.71
TC (mmol/L) 4.56 ± 0.89 4.42 ± 0.73 4.13 ± 0.34 4.36 ± 0.67
Trig (mmol/L) 1.93 ± 1.74 1.68 ± 1.02 1.77 ± 0.38 1.70 ± 0.92
HDL(mmol/L) 1.10 ± 0.37 1.27 ± 0.42 1.14 ± 0.27 1.25 ± 0.39
LDL (mmol/L) 2.77 ± 0.76 2.56 ± 0.70 2.49 ± 0.41 2.55 ± 0.64
apoA (g/L) 1.27 ± 0.19 1.39 ± 0.24 1.31 ± 0.13 1.36 ± 0.20
apoB (g/L) 1.14 ± 0.36 0.98 ± 0.16 1.03 ± 0.20 0.99 ± 0.18
Lp(a) (mg/L) Δ 1.66 ± 0.64 1.67 ± 0.46 1.24 ± 0.04 1.53 ± 0.43
FBS (mmol/L) 9.58 ± 1.80 9.92 ± 2.35 10.31 ± 0.93 10.01 ± 2.11
PPBS (mmol/L) 13.38 ± 3.43 14.05 ± 4.22 15.07 ± 2.73 14.26 ± 3.
RI Δ 1.84 ± 0.27 1.87 ± 0.25 1.77 ± 0.27 1.85 ± 0.25
  1. No statistically significant difference was observed between the gene type groups (P>0.05)
  2. Δ The measurement material were descriptive statistics of skewed distribution, and counted after logarithm